Cargando…

Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia

Late stage Parkinson's disease (PD) patients were commonly observed with other non-motor comorbidities such as dementia and psychosis. While abnormal iron level in the substantia nigra was clinically accepted as a biomarker of PD, it was also suggested that the increased iron deposition could i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Darrell T.H., Hui, Edward S., Chan, Queenie, Yao, N., Chua, S.E., McAlonan, Gráinne M., Pang, Shirley Y.Y., Ho, S.L., Mak, Henry K.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096006/
https://www.ncbi.nlm.nih.gov/pubmed/30128274
http://dx.doi.org/10.1016/j.nicl.2018.07.028
_version_ 1783348030204805120
author Li, Darrell T.H.
Hui, Edward S.
Chan, Queenie
Yao, N.
Chua, S.E.
McAlonan, Gráinne M.
Pang, Shirley Y.Y.
Ho, S.L.
Mak, Henry K.F.
author_facet Li, Darrell T.H.
Hui, Edward S.
Chan, Queenie
Yao, N.
Chua, S.E.
McAlonan, Gráinne M.
Pang, Shirley Y.Y.
Ho, S.L.
Mak, Henry K.F.
author_sort Li, Darrell T.H.
collection PubMed
description Late stage Parkinson's disease (PD) patients were commonly observed with other non-motor comorbidities such as dementia and psychosis. While abnormal iron level in the substantia nigra was clinically accepted as a biomarker of PD, it was also suggested that the increased iron deposition could impair other brain regions and induce non-motor symptoms. A new Magnetic Resonance Imaging (MRI) called Quantitative Susceptibility Mapping (QSM) has been found to measure iron concentration in the grey matter reliably. In this study, we investigated iron level of different subcortical and limbic structures of Parkinson's disease (PD) patients with and without dementia by QSM. QSM and volumetric analysis by MRI were performed in 10 PD dementia (PDD) patients (73 ± 6 years), 31 PD patients (63 ± 8 years) and 27 healthy controls (62 ± 7 years). No significant differences were observed in the L-Dopa equivalent dosage for the two PD groups (p = 0.125). Putative iron content was evaluated in different subcortical and limbic structures of the three groups, as well as its relationship with cognitive performance. One-way ANCOVA with FDR adjustment at level of 0.05, adjusted for age and gender, showed significant group differences for left and right hippocampus (p = 0.015 & 0.032, respectively, BH-corrected for multiple ROIs) and right thalamus (p = 0.032, BH-corrected). Post-hoc test with Bonferroni's correction suggested higher magnetic susceptibility in PDD patients than healthy controls in the left and right hippocampus (p = 0.001 & 0.047, respectively, Bonferroni's corrected), while PD patients had higher magnetic susceptibility than the healthy controls in right hippocampus and right thalamus (p = 0.006 & 0.005, respectively, Bonferroni's corrected). PDD patients also had higher susceptibility than the non-demented PD patients in left hippocampus (p = 0.046, Bonferroni's corrected). The magnetic susceptibilities of the left and right hippocampus were negatively correlated with the Mini-Mental State Examination score (r = −0.329 & -0.386, respectively; p < 0.05). This study provides support for iron accumulation in limbic structures of PDD and PD patients and its correlation with cognitive performance, however, its putative involvement in development of non-motor cognitive dysfunction in PD pathogenesis remains to be elucidated.
format Online
Article
Text
id pubmed-6096006
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60960062018-08-20 Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia Li, Darrell T.H. Hui, Edward S. Chan, Queenie Yao, N. Chua, S.E. McAlonan, Gráinne M. Pang, Shirley Y.Y. Ho, S.L. Mak, Henry K.F. Neuroimage Clin Regular Article Late stage Parkinson's disease (PD) patients were commonly observed with other non-motor comorbidities such as dementia and psychosis. While abnormal iron level in the substantia nigra was clinically accepted as a biomarker of PD, it was also suggested that the increased iron deposition could impair other brain regions and induce non-motor symptoms. A new Magnetic Resonance Imaging (MRI) called Quantitative Susceptibility Mapping (QSM) has been found to measure iron concentration in the grey matter reliably. In this study, we investigated iron level of different subcortical and limbic structures of Parkinson's disease (PD) patients with and without dementia by QSM. QSM and volumetric analysis by MRI were performed in 10 PD dementia (PDD) patients (73 ± 6 years), 31 PD patients (63 ± 8 years) and 27 healthy controls (62 ± 7 years). No significant differences were observed in the L-Dopa equivalent dosage for the two PD groups (p = 0.125). Putative iron content was evaluated in different subcortical and limbic structures of the three groups, as well as its relationship with cognitive performance. One-way ANCOVA with FDR adjustment at level of 0.05, adjusted for age and gender, showed significant group differences for left and right hippocampus (p = 0.015 & 0.032, respectively, BH-corrected for multiple ROIs) and right thalamus (p = 0.032, BH-corrected). Post-hoc test with Bonferroni's correction suggested higher magnetic susceptibility in PDD patients than healthy controls in the left and right hippocampus (p = 0.001 & 0.047, respectively, Bonferroni's corrected), while PD patients had higher magnetic susceptibility than the healthy controls in right hippocampus and right thalamus (p = 0.006 & 0.005, respectively, Bonferroni's corrected). PDD patients also had higher susceptibility than the non-demented PD patients in left hippocampus (p = 0.046, Bonferroni's corrected). The magnetic susceptibilities of the left and right hippocampus were negatively correlated with the Mini-Mental State Examination score (r = −0.329 & -0.386, respectively; p < 0.05). This study provides support for iron accumulation in limbic structures of PDD and PD patients and its correlation with cognitive performance, however, its putative involvement in development of non-motor cognitive dysfunction in PD pathogenesis remains to be elucidated. Elsevier 2018-07-27 /pmc/articles/PMC6096006/ /pubmed/30128274 http://dx.doi.org/10.1016/j.nicl.2018.07.028 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Li, Darrell T.H.
Hui, Edward S.
Chan, Queenie
Yao, N.
Chua, S.E.
McAlonan, Gráinne M.
Pang, Shirley Y.Y.
Ho, S.L.
Mak, Henry K.F.
Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
title Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
title_full Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
title_fullStr Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
title_full_unstemmed Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
title_short Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia
title_sort quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in parkinson's disease with dementia
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096006/
https://www.ncbi.nlm.nih.gov/pubmed/30128274
http://dx.doi.org/10.1016/j.nicl.2018.07.028
work_keys_str_mv AT lidarrellth quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT huiedwards quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT chanqueenie quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT yaon quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT chuase quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT mcalonangrainnem quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT pangshirleyyy quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT hosl quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia
AT makhenrykf quantitativesusceptibilitymappingasanindicatorofsubcorticalandlimbicironabnormalityinparkinsonsdiseasewithdementia